Newrite Medical

Chengdu, China · Founded 2016 · Privately Held (backing)

Developer of targeted therapeutic and diagnostic agents for nuclear medicine applications. Newrite Medical is based in Chengdu, China and was founded in 2016. Its last reported valuation was $32.7 million in Aug 2018. It has raised $331 million.

Last reported valuation
$32.7M
Oct 2026
Priced at
—
Total raised
$330.9M
Last round
—

Who backs Newrite Medical?

28 investors
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Newrite Medical investors

28 investors are on record for Newrite Medical, including Shenzhen Capital Group, Co-Stone Capital, Highlight Capital and Sichuan Venture Capital. By type, the record holds 4 venture capital firms and 1 private equity firm.

Free account
More of Newrite Medical with a free account
  • ·The complete investor list: 28 names
  • ·Watch Newrite Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 28 firms already write checks for companies like Newrite Medical. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View